Home > Healthcare > Medical Devices > Diagnostic Devices > Comprehensive Metabolic Panel Testing Market

Comprehensive Metabolic Panel Testing Market Size

Report ID: GMI7156
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Comprehensive Metabolic Panel Testing Market Size

Comprehensive Metabolic Panel Testing Market size was valued at USD 12.8 billion in 2022 and is estimated to account for USD 29.5 billion by 2032. Comprehensive metabolic panel (CMP) testing is a blood test that provides essential information about the body's chemical balance and metabolism.

To get key market trends

Download Free Sample

The industry is being driven by the growing elderly population base as they are more susceptible to diabetes and cardiovascular ailments. For instance, the WHO estimates that by 2030, there will be 1.4 billion people worldwide that are over 60 years. Thus, surge in geriatric population base coupled with rising chronic diseases is estimated to augment market progress.

Additionally, one of the diseases with the largest global growth rates is diabetes, which increases the patient population for point-of-care (PoC) comprehensive metabolic panel testing. Over the projection period, it is predicted that the prevalence of cardiovascular, diabetes, and other target illnesses would increase, driving up demand for comprehensive metabolic panel testing. Nearly 17.9 million people die each year as a result of cardiovascular illnesses (CVDs).

Comprehensive Metabolic Panel Testing Market Report Attributes
Report Attribute	Details
Base Year:	2022
Comprehensive Metabolic Panel Testing Market Size in 2022:	USD 12.8 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	8.7 %
2032 Value Projection:	USD 29.5 Billion
Historical Data for:	2018 to 2022
No. of Pages:	256
Tables, Charts & Figures:	401
Segments covered:	Test Type, Disease Indication, End-use, and Region
Growth Drivers:	Increasing prevalence of diabetes Technological advancements in comprehensive metabolic panel testing Growing awareness regarding early diagnosis and treatment of diseases Growing inclination towards usage of point of care devices
Pitfalls & Challenges:	Lack of reimbursement scenario Stringent regulatory scenario

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global comprehensive metabolic panel testing industry was valued at USD 12.8 billion in 2022 and is estimated to account for USD 29.5 billion by 2032.

The glucose segment garnered USD 3.1 billion in 2022 and will continue to grow as it provides essential information about an individual's blood sugar levels and is an indicator of various metabolic disorders, including metabolic syndrome.

U.S. comprehensive metabolic panel testing market accounted for USD 4.9 billion in 2022 and is predicted to grow through 2032, primarily attributed to the annual increase in the demand for diagnostic tests, advanced healthcare infrastructure, and leadership in innovative medical practices.

Abbott Laboratories, Quest Diagnostics, Laboratory Corporation of America Holdings Limited, Sonic Healthcare, Unipath, SYNLAB International GmbH, ARUP Laboratories, Genoptix Inc., and Nova Medical among others.